Darzalex

Darzalex (daratumumab) is a monoclonal antibody used in the treatment of certain blood cancers. This intravenous medication targets specific proteins on cancer cells to help manage conditions like multiple myeloma.

Darzalex is primarily used in the treatment of multiple myeloma, a type of blood cancer. It works by targeting a protein called CD38, which is found on the surface of certain cancer cells. This helps the immune system recognize and destroy these cells. Daratumumab is often used in combination with other treatments to manage this condition.

Common effects of Darzalex may include infusion reactions, such as fever, chills, and shortness of breath. Other possible effects include fatigue, nausea, and upper respiratory tract infections. These effects can vary from person to person and may not affect everyone who uses this medication.

Darzalex should be administered under the supervision of a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions you have before starting treatment. Regular monitoring may be required to manage potential side effects and ensure the medication is working as intended.

Darzalex may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect how this medication works, so it is best to follow your healthcare provider's advice on diet and lifestyle during treatment.